SAVIENT PHARMACEUTICALS $0.74

down -0.01


18/6/2013 04:18 PM  |  NASDAQ : SVNT  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/22/2013 FERRARI LOUIS President and CEO -1,020 $0.57 -0.33%
4/30/2013 Bahrt Kenneth SVP, Chief Medical Officer -1,250 $0.74 -0.70%
4/30/2013 CROWLEY Richard EVP, Chief Operating Officer -2,485 $0.74 -0.86%
3/6/2013 Gionco David Group VP & Chief Acct. Officer -1,560 $0.93 -1.83%
2/25/2013 FERRARI LOUIS President and CEO -375 $0.99 -0.13%
2/4/2013 YACHMETZ PHILIP K SVP, General Counsel -3,203 $1.02 -1.04%
2/4/2013 YACHMETZ PHILIP K SVP, General Counsel -27,297 $1.01 -8.17%
2/4/2013 FERRARI LOUIS President and CEO -3,200 $1.02 -1.07%
2/4/2013 FERRARI LOUIS President and CEO -59,000 $1.01 -16.45%
2/4/2013 CROWLEY Richard EVP, Biopharmaceutical Ops -30,000 $1.05 -9.43%
2/4/2013 CROWLEY Richard EVP, Biopharmaceutical Ops -18,900 $1.01 -5.61%
2/4/2013 Bahrt Kenneth SVP, Chief Medical Officer -21,700 $1.04 -11.22%
2/4/2013 Bahrt Kenneth SVP, Chief Medical Officer -7,300 $1.01 -3.64%
1/31/2013 Bahrt Kenneth SVP, Chief Medical Officer -1,300 $1.03 -0.64%
1/31/2013 CROWLEY Richard EVP, Biopharmaceutical Ops -2,415 $1.02 -0.71%
1/14/2013 YACHMETZ PHILIP K SVP, General Counsel -1,283 $1.14 -0.38%
11/26/2012 FERRARI LOUIS President and CEO -950 $1.16 -0.26%
10/31/2012 CROWLEY Richard EVP, Biopharmaceutical Ops -2,010 $1.45 -0.59%
10/31/2012 Bahrt Kenneth SVP, Chief Medical Officer -1,000 $1.45 -0.49%
8/22/2012 FERRARI LOUIS President and CEO -984 $1.00 -0.28%
8/2/2012 CROWLEY Richard EVP, Biopharma Operatiotions -2,500 $0.62 -0.73%
8/1/2012 Bahrt Kenneth SVP, Chief Medical Officer -4,950 $0.62 -2.38%
5/22/2012 Constantine Ginger Director 49,382 $0.81 315.88%
5/22/2012 THOMPSON VIRGIL Director 49,382 $0.81 82.04%
5/22/2012 Owen William F Director 49,382 $0.81 681.22%
5/22/2012 JAEGER STEPHEN O Director 98,765 $0.81 148.20%
5/22/2012 FERRARI LOUIS EVP, North American Commerical -942 $0.82 -0.27%
5/1/2012 CROWLEY Richard EVP Biopharmaceutical Operatio -9,200 $2.35 -2.61%
2/27/2012 YACHMETZ PHILIP K SVP, General Counsel 100,000 $2.10 42.47%
2/22/2012 FERRARI LOUIS EVP, North American Commerical -4,100 $2.06 -1.16%
2/14/2012 YACHMETZ PHILIP K SVP, General Counsel -3,540 $2.02 -1.48%
2/1/2012 FERRARI LOUIS EVP, N American Commerical Ops 310,000 $2.26 695.02%
2/1/2012 YACHMETZ PHILIP K SVP, General Counsel 50,000 $2.26 26.45%
2/1/2012 CROWLEY Richard EVP, Biopharmaceutical Ops 250,000 $2.26 242.72%
2/1/2012 Bahrt Kenneth SVP, Chief Medical Officer 150,000 $2.26 258.62%
11/30/2011 FERRARI LOUIS EVP, N American Commerical Ops 381 $2.13 0.86%
11/21/2011 FERRARI LOUIS SVP, North American Commerical 4,000 $2.29 10.00%
11/21/2011 CROWLEY Richard EVP Biopharmaceutical Operatio 3,000 $2.53 3.00%
11/21/2011 JOHNSON JOHN CEO & President 5,000 $2.30 1.89%
11/18/2011 JOHNSON JOHN CEO & President 10,000 $2.28 3.92%
11/18/2011 JOHNSON JOHN CEO & President 1,000 $2.36 33.33%
11/18/2011 ZUERBLIS KENNETH J EVP, Chief Financial Officer 2,000 $2.35 40.00%
11/16/2011 Bahrt Kenneth SVP, Chief Medical Officer 5,000 $2.59 9.43%
9/16/2011 YACHMETZ PHILIP K SVP, General Counsel 7,000 $4.13 3.85%
9/16/2011 JOHNSON JOHN CEO & President 1,500 $4.09 100.00%
9/16/2011 JOHNSON JOHN CEO & President 25,000 $4.10 10.87%
9/15/2011 ZUERBLIS KENNETH J EVP, Chief Financial Officer 4,000 $4.05 400.00%
9/15/2011 HELLER ALAN L Director 7,500 $3.99 22.95%
9/14/2011 Bahrt Kenneth SVP, Chief Medical Officer 500 $3.97 0.95%
9/14/2011 Bahrt Kenneth SVP, Chief Medical Officer 2,500 $3.95 5.00%
8/31/2011 FERRARI LOUIS EVP, N American Commerical Ops 222 $3.66 0.50%
7/31/2011 Bahrt Kenneth SVP, Chief Medical Officer -50,000 $7.00 -50.00%
5/26/2011 Constantine Ginger Director 5,291 $7.78 51.16%
5/26/2011 JAEGER STEPHEN O Director 10,582 $7.78 18.88%
5/26/2011 HELLER ALAN L Director 5,291 $7.78 19.32%
5/26/2011 THOMPSON VIRGIL Director 5,291 $7.78 9.64%
5/26/2011 Simon Lee S Director 5,291 $7.78 22.15%
4/30/2011 CROWLEY Richard EVP Biopharmaceutical Operatio -100,000 $11.62 -50.00%
2/14/2011 Hamelin Paul President -5,371 $9.89 -4.13%
2/14/2011 YACHMETZ PHILIP K SVP, General Counsel -3,210 $9.88 -1.73%
1/24/2011 Gionco David Group VP & CFO -2,032 $10.00 -4.54%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (SVNT), click here.
Marketplace
Trading Center